Structural Variation : A Circadian Biomarker Associated with Breast Cancer in Young Women

Circadian disruption has been indicated as a risk factor for breast cancer in recent epidemiologic studies. A novel finding in circadian biology is that genes responsible for circadian rhythm also regulate many other biological pathways, including cell proliferation, cell cycle regulation, and apoptosis. Therefore, mutations in circadian genes could conceivably result in deregulation of these processes and contribute to tumor development, and be markers for susceptibility to human cancer. In this study, we investigated the association between an exonic length variation in a circadian gene, Period3 (Per3), and breast cancer risk using blood samples collected from a recently completed breast cancer case-control study in Connecticut. There were 389 Caucasian cases and 432 Caucasian controls included in our analysis. We found that the variant Per3 genotype (heterozygous + homozygous 5-repeat alleles) was associated with an increased risk of breast cancer among premenopausal women (odds ratio, 1.7; 95% confidence interval, 1.0-3.0). Our finding suggests that the circadian genes might be a novel panel of potential biomarkers for breast cancer and worth further investigation. (Cancer Epidemiol Biomarkers Prev 2005;14(1):268–70)

[1]  S. Edge,et al.  Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. , 2003, The Surgical clinics of North America.

[2]  Josephine Arendt,et al.  A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. , 2003, Sleep.

[3]  L. Fu,et al.  The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.

[4]  T. Paunio,et al.  Circadian Clock-Related Polymorphisms in Seasonal Affective Disorder and their Relevance to Diurnal Preference , 2003, Neuropsychopharmacology.

[5]  Peng Huang,et al.  The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo , 2002, Cell.

[6]  W. Hrushesky,et al.  Fertility Cycle Influence on Surgical Breast Cancer Cure , 2002, Breast Cancer Research and Treatment.

[7]  Kai-Florian Storch,et al.  Extensive and divergent circadian gene expression in liver and heart , 2002, Nature.

[8]  Francis Lévi,et al.  Host circadian clock as a control point in tumor progression. , 2002, Journal of the National Cancer Institute.

[9]  R. Stevens,et al.  Night shift work, light at night, and risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[10]  F Laden,et al.  Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. , 2001, Journal of the National Cancer Institute.

[11]  Mark S. Rea,et al.  Light in the Built Environment: Potential role of Circadian Disruption in Endocrine Disruption and Breast Cancer , 2001, Cancer Causes & Control.

[12]  Yuichi Inoue,et al.  Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome , 2001, EMBO reports.

[13]  R. Demicheli,et al.  Premenopausal Status Accelerates Relapse in Node Positive Breast Cancer: Hypothesis Links Angiogenesis, Screening Controversy , 2001, Breast Cancer Research and Treatment.

[14]  G. Giles,et al.  After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. , 2001, American journal of human genetics.

[15]  Johnni Hansen,et al.  Increased Breast Cancer Risk among Women Who Work Predominantly at Night , 2001, Epidemiology.

[16]  P. Boyle,et al.  Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  L. E. Anderson,et al.  Effect of constant light on DMBA mammary tumorigenesis in rats , 2000, Cancer Letters.

[18]  R. Stevens,et al.  Inverse association between breast cancer incidence and degree of visual impairment in Finland , 1999, British Journal of Cancer.

[19]  M. W. Young,et al.  A light‐independent oscillatory gene mPer3 in mouse SCN and OVLT , 1998, The EMBO journal.

[20]  R. Hahn,et al.  Profound bilateral blindness and the incidence of breast cancer. , 1991, Epidemiology.

[21]  A. Bluming,et al.  The Effect of Surgical Timing within the Fertility Cycle on Breast Cancer Outcome a , 1991, Annals of the New York Academy of Sciences.

[22]  M. Mhatre,et al.  Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. , 1984, Cancer research.

[23]  R. Demicheli,et al.  Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  F. Opri,et al.  Menstrual timing of breast cancer surgery , 1998, American journal of surgery.